What You Should Know About Safety

Toxicity appears to be dependent upon both dosage and the rate of administration. Detoxamin, the only patented EDTA suppository, is far safer to use and has less side effects than I.V. or oral EDTA chelation therapy. The usual array of side effects observed in intravenous infusions are absent when taken by Detoxamin Suppositories. Renal excretory function should be within normal limits prior to treatment. Renal toxicity, such as encountered in intravenous administering of EDTA, are not present in Detoxamin Therapy.

We reduced the dosage in Detoxamin for a safer administration of EDTA and to provide better EDTA assimilation by more frequency of treatment. We have found that EDTA metabolizes differently (slower) and coincidentally it does not dump on the kidney and liver at one time. Of course because of the lower dosage administered more frequently, it makes it a much safer for the body to handle it.

Detoxamin truly revolutionizes EDTA chelation therapy because it not only produces results that are equal to but in many cases are better than intravenous administration results. Simply better, safer form chelation.